SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership:
SEC Accession No. 0001193125-18-042686
Filing Date
2018-02-13
Accepted
2018-02-13 16:40:11
Documents
1
Group Members
ESHELMAN VENTURES, LLC

Document Format Files

Seq Description Document Type Size
1 SC 13D d509355dsc13d.htm SC 13D 55704
  Complete submission text file 0001193125-18-042686.txt   57143
Mailing Address PPD INC 929 NORTH FRONT STREET WILMINGTON NC 28401
Business Address
ESHELMAN FREDRIC N (Filed by) CIK: 0001033409 (see all company filings)

Type: SC 13D

Mailing Address P. O. BOX # 110341 RESEARCH TRIANGLE PARK NC 27709
Business Address 79 T.W. ALEXANDER DRIVE 4501 RESEARCH COMMONS, SUITE 100 RESEARCH TRIANGLE PARK NC 27709 919-213-9835
G1 Therapeutics, Inc. (Subject) CIK: 0001560241 (see all company filings)

IRS No.: 263648180 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-90214 | Film No.: 18604071
SIC: 2834 Pharmaceutical Preparations